Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: A study of patients from the Southeast Region of Iran

Inflammation

Volumn 35, Issue 3, 2012, Pages 797-802

  Arababadi, Mohammad Kazemi ^a   Mirzaei, Mohammad Reza ^a   Sajadi, Seyed Mohammad Ali ^a   Hassanshahi, Gholamhossein ^a   Ahmadabadi, Behzad Nasiri ^a   Salehabadi, Vajihe Akbarpour ^a   Derakhshan, Reza ^a   Kennedy, Derek ^b  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Diabetes; IL 10; Nephropathy; Polymorphism

Indexed keywords

INSULIN; METFORMIN;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DNA DETERMINATION; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTERLEUKIN 10 GENE; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; IRAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863795418     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9376-7     Document Type: Article

References (34)

1. Steyn, N.P., E.V. Lambert, and H. Tabana. 2008. Nutrition interventions for the prevention of type 2 diabetes. Proc Nutr Soc 10: 1-16.
2. Zimmet, P., K.G. Alberti, and J. Shaw. 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782-787. (Pubitemid 34000780)
3. Nathanson, D., and T. Nystrom. 2008. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium. Mol Cell Endocrinol 21: 21.
4. Cruz, M., C. Maldonado-Bernal, R. Mondragon-Gonzalez, R. Sanchez-Barrera, N.H. Wacher, G. Carvajal-Sandoval, and J. Kumate. 2008. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. J Endocrinol Invest 31: 694-699.
5. Giulietti, A., E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, and C. Mathieu. 2007. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77: 47-57. (Pubitemid 46590467)
6. Tsiavou, A., D. Degiannis, E. Hatziagelaki, K. Koniavitou, and S.A. Raptis. 2004. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J Interferon Cytokine Res 24: 381-387. (Pubitemid 38998786)
7. Arababadi, M.K., R. Nosratabadi, G. Hassanshahi, N. Yaghini, V. Pooladvand, A. Shamsizadeh, H. Hakimi, and R. Derakhshan. 2009. Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases? Diabetes Res Clin Pract 87: 33-37.
8. Skopinski, P., E. Rogala, B. Duda-Krol, A. Lipinska, E. Sommer, J. Chorostowska-Wynimko, J. Szaflik, I. Partyka, and E. Skopinska-Rozewska. 2005. Increased interleukin-18 content and angiogenic activity of sera from diabetic (type 2) patients with background retinopathy. J Diabetes Complications 19: 335-338. (Pubitemid 41563016)
9. Pickup, J.C., G.D. Chusney, S.M. Thomas, and D. Burt. 2000. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 67: 291-300. (Pubitemid 30413937)
10. Suppiah, V., A. Goris, I. Alloza, S. Heggarty, B. Dubois, H. Carton, A. Antiguedad, M. Mendibe, G. McDonnell, A. Droogan, S. Hawkins, C. Graham, and K. Vandenbroeck. 2005. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations. Int J Immunogenet 32: 383-388. (Pubitemid 41735577)
11. Lopez, P., C. Gutierrez, and A. Suarez. 2010. IL-10 and TNFalpha genotypes in SLE. J Biomed Biotechnol 2010: 838390.
12. Chen, J., and X. Liu. 2009. The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. Cell Immunol 254: 85-90.
13. Amirzargar, M., M. Yavangi, A. Basiri, S.H. Moghadam, F. Khosravi, G. Solgi, M. Gholiaf, F. Khoshkho, F. Dadaras, M. Mahmmodi, B. Ansaripour, A. Amirzargar, and B. Nikbin. 2007. Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients. Transplant Proc 39: 954-957. (Pubitemid 46779059)
14. Wang, X.H., W. Zhao, S.G. Liu, and X.P. Feng. 2009. Correlation of IL-4 and IL-13 gene polymorphisms with asthma and total serum IgE levels. Zhonghua Jie He He Hu Xi Za Zhi 32: 161-164.
15. Luczynski, W., A. Stasiak-Barmuta, A. Juchniewicz, N. Wawrusiewicz-Kurylonek, E. Ilendo, J. Kos, A. Kretowski, M. Gorska, L. Chyczewski, and A. Bossowski. 2010. The mRNA expression of pro- and anti-inflammatory cytokines in T regulatory cells in children with type 1 diabetes. Folia Histochem Cytobiol 48: 93-100.
16. Sanjabi, S., L.A. Zenewicz, M. Kamanaka, and R.A. Flavell. 2009. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9: 447-453.
17. Karjalainen, J., J. Hulkkonen, M.M. Nieminen, H. Huhtala, A. Aromaa, T. Klaukka, and M. Hurme. 2003. Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy 33: 78-83. (Pubitemid 36114911)
18. Momeni, A., S. Shahidi, S. Seirafian, S. Taheri, and S. Kheiri. 2011. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis 4: 128-132.
19. Brown, S. 2010. Re: estimation of glomerular filtration rate with creatinine-based versus cystatin C-based equations in kidney transplant recipients. Iran J Kidney Dis 4: 169-170.
20. Enriquez, R., A.E. Sirvent, E. Andrada, C. Escolano, J.C. Rodriguez, I. Millan, F. Gutierrez, and F. Amoros. 2010. Cryoglobulinemic glomerulonephritis in chronic hepatitis B infection. Ren Fail 32: 518-522.
21. Hrbacek, J., P. Konopasek, V. Eis, E. Hamsikova, R. Tachezy, J. Pokorny, K. El-Balouly, M. Urban, and J. Heracek. 2011. Urologic complications of HIV infection. Cas Lek Cesk 149: 115-119.
22. King, G.L. 2008. The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79: 1527-1534.
23. Murugan, A.T., and G. Sharma. 2008. Obesity and respiratory diseases. Chron Respir Dis 5: 233-242.
24. Fagard, R.H., and P.M. Nilsson. 2009. Smoking and diabetes - the double health hazard! Prim Care Diabetes 3: 205-209.
25. Cignarelli, M., O. Lamacchia, S. Di Paolo, and L. Gesualdo. 2008. Cigarette smoking and kidney dysfunction in diabetes mellitus. J Nephrol 21: 180-189.
26. Arababadi, M.K., N. Naghavi, G. Hassanshahi, and M. Mahmoodi. 2009. Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes? Ann Saudi Med 29: 413.
27. Arababadi, M.K., A.A. Pourfathollah, A. Jafarzadeh, and G. Hassanshahi. 2010. Serum levels of interleukin (IL)-10 and IL-17A in occult HBV infected south-east Iranian patients. Hepat Mon 10(1): 31-35.
28. Arababadi, M.K., A.A. Pourfathollah, S. Daneshmandi, G. Hassanshahi, E.R. Zarandi, A. Shamsizadeh, M.A. Rezaei, and S. Eigder. 2009. Evaluation of relation between IL-4 and IFN-g polymorphisms and type 2 diabetes. Iran J Bas Med Scie 12(2): 100-104.
29. Ezzidi, I., N. Mtiraoui, M. Kacem, S.G. Mallat, M.B. Mohamed, M. Chaieb, T. Mahjoub, and W.Y. Almawi. 2009. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clin Endocrinol (Oxf) 70: 401-407.
30. Scarpelli, D., M. Cardellini, F. Andreozzi, E. Laratta, M.L. Hribal, M.A. Marini, V. Tassi, R. Lauro, F. Perticone, and G. Sesti. 2006. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 55: 1529-1533. (Pubitemid 44195398)
31. Chang, Y.H., C.N. Huang, C.Y. Wu, and M.Y. Shiau. 2005. Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol 66: 1258-1263.
32. Mtiraoui, N., I. Ezzidi, M. Kacem, M. Ben Hadj Mohamed, M. Chaieb, A.B. Haj Jilani, T. Mahjoub, and W.Y. Almawi. 2009. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes Metab Res Rev 25: 57-63.
33. Kolla, V.K., G. Madhavi, B. Pulla Reddy, B.M. Srikanth Babu, J. Yashovanthi, V.L. Valluri, J. Ramesh, and J. Akka. 2009. Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine 47: 173-177.
34. Arababadi, M.K. 2010. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy. Iran J Kidney Dis 4: 302-306.